Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer.
Ciruelos, Eva
Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer. [electronic resource] - Anti-cancer drugs Sep 2013 - 769-80 p. digital
Publication Type: Journal Article; Review
1473-5741
10.1097/CAD.0b013e328363adc5 doi
Androstadienes--administration & dosage
Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Aromatase Inhibitors--administration & dosage
Biomarkers, Tumor--metabolism
Breast Neoplasms--drug therapy
Disease-Free Survival
Everolimus
Female
Humans
Molecular Targeted Therapy
Protein Kinase Inhibitors--administration & dosage
Signal Transduction--drug effects
Sirolimus--administration & dosage
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome
Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer. [electronic resource] - Anti-cancer drugs Sep 2013 - 769-80 p. digital
Publication Type: Journal Article; Review
1473-5741
10.1097/CAD.0b013e328363adc5 doi
Androstadienes--administration & dosage
Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Aromatase Inhibitors--administration & dosage
Biomarkers, Tumor--metabolism
Breast Neoplasms--drug therapy
Disease-Free Survival
Everolimus
Female
Humans
Molecular Targeted Therapy
Protein Kinase Inhibitors--administration & dosage
Signal Transduction--drug effects
Sirolimus--administration & dosage
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome